Open AccessOnly 9 weeks or complete 12 months of adjuvant trastuzumab in Indian early-stage breast cancer patients: Is it the practice-changing approach in a resource-constrained setting?
Author(s) -
ChaturbhujR Agrawal,
Kshitiz Domadia,
Pankaj Goyal
Publication year - 2020
Publication title -
cancer research, statistics, and treatment/cancer research, statistics and treatment
Language(s) - English
Resource type - Journals
eISSN - 2590-3233
pISSN - 2590-3225
DOI - 10.4103/crst.crst_75_20
Subject(s) - trastuzumab , stage (stratigraphy) , adjuvant , breast cancer , medicine , oncology , cancer , biology , paleontology